2017. ID:2037 Molecular mechanisms underlying resistance to MEK1/2 inhibitor in BRAF-mutated colorectal cancer. Biomedical Research and Therapy. 4, S (Sep. 2017), S68. DOI:https://doi.org/10.15419/bmrat.v4iS.276.